By: Chris Gouveia, MD
Surgical therapy for obstructive sleep apnea (OSA) remains misunderstood and inconsistently applied amongst sleep providers. For many clinicians, surgery is viewed as a last resort after CPAP failure; because of this, it is an underutilized option that may meaningfully reduce disease burden or improve patient satisfaction when thoughtfully selected. As our field moves toward phenotype-driven OSA management, understanding the modern workflow for surgical evaluation—and how it integrates with non-surgical therapies—is increasingly important for the multidisciplinary sleep team.
This review outlines a practical approach to surgical evaluation for OSA, from patient selection to surgical options, follow-up, and assessment of effectiveness.
Step 1: Patient Selection — Who Should Be Referred?
Surgical consultation should not be reserved solely for patients who have “failed everything else.” Appropriate candidates often include:
- Patients intolerant of CPAP despite adequate attempts at optimization
- Patients with persistent symptoms or residual OSA despite CPAP, oral appliance, or positional therapy
- Patients with clear anatomic contributors to obstruction (e.g., tonsillar hypertrophy, nasal obstruction, craniofacial features)
- Patients seeking alternatives or adjuncts to lifelong device therapy
Importantly, severity alone should not exclude referral. Patients with mild to moderate OSA and disproportionate symptoms or anatomic obstruction may derive meaningful benefit from targeted intervention.
Key elements of the referral packet should include:
- Diagnostic sleep study (preferably within 2–3 years)
- Prior PAP data and adherence history
- BMI trends and weight stability
- Prior airway surgeries or dental appliances
Step 2: Surgical Evaluation — Anatomy, Physiology, and Phenotype
The surgical consultation begins with a comprehensive upper airway assessment, typically including:
- Nasal examination (septal deviation, turbinate hypertrophy, valve collapse)
- Oropharyngeal exam (tonsil size, Friedman stage)
- Tongue size, dental occlusion, mandibular position
- Neck circumference and craniofacial structure
Many surgeons now incorporate drug-induced sleep endoscopy (DISE) to assess dynamic collapse patterns at the velum, oropharynx, tongue base, and epiglottis. DISE is particularly helpful when considering:
- Multilevel surgery
- Hypoglossal nerve stimulation candidacy
- Failed prior surgery or CPAP intolerance without obvious static obstruction
From a sleep medicine perspective, this step represents a shift away from “one-size-fits-all” surgery toward phenotype-directed intervention.
Step 3: Surgical Options — Targeted, Multilevel, and Implantable Therapies
Beyond their individual utility, the most important point in selection is patient goals (degree of health improvement, snoring burden, and quality of life impact weighed against the potential risks of surgery). Surgical therapies for OSA broadly fall into several categories:
- Nasal Surgery
Septoplasty, turbinate reduction, and nasal valve repair rarely cure OSA alone, but can:
- Improve CPAP tolerance
- Reduce oral breathing
- Improve sleep quality and adherence to other therapies
- Palatal Surgery
Traditional uvulopalatopharyngoplasty (UPPP) has evolved into multiple targeted approaches, including:
- Expansion sphincter pharyngoplasty
- Lateral pharyngoplasty
- Palatal advancement techniques
These are all aimed at widening/stiffening the throat to allow better airflow. When appropriately selected, modern palatal surgery can significantly reduce AHI and symptoms.
- Tongue Base and Hypopharyngeal Surgery
Options include:
- Radiofrequency ablation
- Lingual tonsillectomy
- Tongue suspension
- Transoral robotic surgery (TORS) in select cases
- Skeletal Surgery
Maxillomandibular advancement (MMA) remains the most effective surgical intervention for OSA in terms of AHI reduction, though it is invasive and best suited for carefully selected patients. It requires orthodontic management before and after as well.
- Hypoglossal Nerve Stimulation
HNS has emerged as a major option for patients with:
- Moderate–severe OSA
- BMI within device-specific thresholds
- Favorable DISE findings (no complete concentric collapse)
Inspire has been FDA approved since 2014, and two new options (Nyxoah and LivaNova) are being made available soon.
Step 4: Post-Operative Follow-Up and Assessment of Effectiveness
Follow-up is a critical but sometimes underemphasized component of surgical care. Best practices include:
- Early post-operative assessment for healing, dysphagia, pain, and sleep quality
- Repeat sleep testing (HSAT or PSG) typically 3–6 months post-intervention
- Ongoing symptom tracking (ESS, snoring, quality of life)
- Coordination with the referring sleep physician to reassess need for adjunctive therapy
Success should not be defined solely by “cure.” Given sensitivity of sleep testing, this is rarely achieved. Meaningful outcomes include:
- Reduction in AHI or hypoxic burden
- Improved symptoms and daytime function
- Improved tolerance of PAP or oral appliance therapy
- Reduction in treatment complexity or burden
The Role of the Multidisciplinary Sleep Team
Surgical management of OSA works best when integrated into a collaborative care model involving sleep physicians, dentists, surgeons, technologists, and APPs. Clear communication around expectations, goals, and post-operative management is essential.
As OSA care increasingly shifts toward personalized treatment pathways, surgical evaluation should be viewed not as a last resort, but as one component of a broader therapeutic toolkit.
Selected References
- Weaver EM, et al. Judging sleep apnea surgery. Sleep Med Rev. 2010.
- Caples SM, et al. Surgical modifications of the upper airway for OSA. Sleep. 2010.
- Kent D, et al. Referral of adults with obstructive sleep apnea for surgical consultation: an American Academy of Sleep Medicine clinical practice guideline. J Clan Sleep Med. 2021.